Transfusion therapy is a life-sustaining treatment for patients with
sickle cell disease (SCD), but can cause serious complications including
alloimmunization. We previously reported diminished regulatory T cells (Tregs)
and skewed Th2 responses in alloimmunized SCD patients. We hypothesized that the
B cell regulatory (Breg) compartment, which controls Treg and Th
differentiation, may also be compromised in allosensitized SCD patients.
Phenotypically, we did not find differences in the frequency or numbers of
CD24hiCD38hi and CD24hiCD27+ B
cell subsets, both previously identified as human Bregs, between alloimmunized
and non-alloimmunized SCD patients on regular transfusions. However, at the
functional level, CD19+ B cells from alloimmunized SCD patients expressed lower
levels of IL-10 following stimulation as compared with non-alloimmunized
patients (p<0.05), and had reduced ability in inhibiting autologous CD14+
monocyte TNF-α expression (p<0.05). These findings suggest that
Bregs from alloimmunized and non-alloimmunized SCD patients differ in their
ability to produce IL-10 and dampen monocyte activation, all consistent with an
altered immunoregulatory state in alloimmunized SCD patients.